AGRX - Agile Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts4144
Avg. Estimate-0.12-0.12-0.6-0.46
Low Estimate-0.15-0.12-0.62-0.66
High Estimate-0.09-0.12-0.57-0.27
Year Ago EPS-0.18-0.2-0.91-0.6
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts4144
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.24-0.2-0.17-0.15
EPS Actual-0.18-0.2-0.16-0.11
Difference0.0600.010.04
Surprise %25.00%0.00%5.90%26.70%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.12-0.12-0.6-0.46
7 Days Ago-0.12-0.12-0.6-0.46
30 Days Ago-0.140-0.61-0.6
60 Days Ago-0.140-0.58-0.68
90 Days Ago-0.140-0.62-0.82
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 Days1N/A32
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAGRXIndustrySectorS&P 500
Current Qtr.33.30%N/AN/A0.48
Next Qtr.40.00%N/AN/A0.40
Current Year34.10%N/AN/A0.21
Next Year23.30%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A